CD4 and common variable immunodeficiency: Multiple studies show a stable specific SARS-CoV-2 CD4 + cellular immune response between 2 weeks and 6 months after second COVID-19 vaccination in healthy individuals [9, 32, 33] and for CVID patients [8].